
Can ADHD Raise Your Risk of Irritable Bowel Syndrome? Study Offers Clues
A new study indicates there may be an association between attention deficit hyperactivity disorder (ADHD) and irritable bowel syndrome (IBS).
Researchers say an altered gut microbiome may be one of the main factors for this connection.
Further study is warranted, as one expert doesn't believe there is a correlation between the two conditions.
In a new meta-analysis, scientists say they have established a 'significant positive association' between attention deficit hyperactivity disorder (ADHD) and a higher risk of irritable bowel syndrome (IBS).
The researchers said an altered gut microbiome may be the 'potential link that bridges the gap between ADHD and intestinal disorder.'
Their findings were published recently in the journal Scientific Reports.
The researchers said their analysis has significance in the daily lives of people with ADHD.
'IBS considerably affects quality of life in affected patients. Its presence in ADHD patients may further complicate the management of ADHD,' they wrote.
'Our results suggest that gut microbiome may explain the link between ADHD and IBS. Our finding of the positive association between ADHD and IBS suggests that clinicians should be aware of gastrointestinal symptoms in children and adults with ADHD,' they added.
The researchers noted there were several limitations to their analysis. They said that nearly half of the studies they examined were from Asia and only two studies included people of all ages.
One expert not involved in the study is highly critical of the research.
'I am highly critical of the study design, findings, and conclusions. The studies included into this meta-analysis are very heterogenous in terms of age, geographical region, study size, study design and probably in terms of diagnostic criteria used for IBS and ADHD,' said Emeran Mayer, MD, a professor of psychology medicine at the University of California Los Angeles and the director of the UCLA Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress.
'It is also highly likely that different diagnostic criteria were used for some of the IBS studies. Previous well-designed studies have shown no correlation between IBS and ADHD,' Mayer told Healthline.
Are IBS and ADHD linked?
To reach their conclusions, the researchers analyzed 11 past studies with 3.8 million individuals, including about 175,000 people with ADHD.
The 11 studies that were examined were all published within the past 25 years.
The researchers reported that the risk of IBS in people with ADHD was 1.63 times greater than in people who don't have ADHD.
They added their research did not demonstrate an association between ADHD and other intestinal disorders.
The scientists noted that an altered gut microbiome has been implicated in a variety of neuropsychiatric disorders, including Parkinson's disease, multiple sclerosis, and Alzheimer's disease.
They added that children with ADHD tend to have more gastrointestinal issues, such as constipation and flatulence, than children without the condition.
They said these past studies have indicated that there is a connection between the gut-brain axis and ADHD.
Mayer isn't convinced.
'The study is purely correlational and does not provide any evidence for a causal relationship between ADHD and IBS, or between gut microbiome and ADHD prevalence,' he said.
'On the other hand, given the high comorbidity of ADHD with other psychiatric disorders, including anxiety, and the high comorbidity of IBS with anxiety and depression, a correlation between IBS and ADHD is likely. IBS is a disorder of altered gut-brain interactions characterized by higher anxiety levels. Consistent alteration in the gut microbiome in IBS patients has not been reported.'
Max Wiznitzer, MD, pediatric neurologist at Rainbow Babies & Children's Hospital, professor of pediatrics and neurology at Case Western Reserve University in Cleveland, and co-chair of the Professional Advisory Board at the Children and Adults with Attention Deficit Hyperactive Disorder (CHADD), said there are other better explanations for the association between ADHD and IBS. Wiznitzer wasn't involved in the study.
'It is likely due to comorbid anxiety and/or depression,' Wiznitzer told Healthline.
'With the failure [of the researchers] to recognize or comment on the likely association with comorbid depression or anxiety by Ng et al in the Scientific Reports, the value of their conclusions is questionable (i.e., it is likely that the comorbid condition and not the ADHD is the reason for the association). Furthermore, they focus so much on gut microbiota that they overlook other potential reasons,' he noted.
What to know about ADHD
Attention-deficit hyperactivity disorder is described as a mental health condition that can cause impulsive behaviors.
Symptoms of ADHD include:
difficulty focusing on a task
being easily distracted
unable to sit still for an extended period time
interrupting people while they are talking
The American Psychiatric Association lists three different types of ADHD. They are:
predominantly inattentive
predominantly hyperactivity-impulsive
a combination of both types
Scientists are still uncertain of the underlying cause of ADHD, although they believe genetics may be involved.
The researchers in the current study note that ADHD has been linked to a wide range of consequences for individuals.
These included an increased risk of smoking, substance-related disorders, sexual risk-taking behavior, greater driving risk, and suicidal behavior. They added that the chronic condition also poses a significant economic burden on families and society.
ADHD is generally diagnosed in children, although the condition can be present in adults. The condition is more prevalent in boys than in girls.
Treatments for ADHD include behavioral therapy and medication. A balanced diet, regular exercise, adequate sleep, and limiting screen time on phones, computers, and television are also recommended.
Mayer said there are therapies that can be beneficial.
'There is a number of behavioral techniques that have been used successfully in patients with ADHD. Similar cognitive behavioral techniques have been shown to benefit patients with IBS,' he said.
What to know about IBS
Irritable bowel syndrome is a group of intestinal symptoms that can include abdominal cramping, bloating, gas, diarrhea, and constipation.
The condition is more common in women than in men. It also tends to affect younger adults more often than older adults.
The symptoms are mild in some people but can be serious enough in other people to disrupt their daily lives.
The exact cause of IBS is not known, although an oversensitive colon and immune system difficulties are potential factors.
Triggers for IBS can include stress and anxiety. Some foods can also trigger IBS. They include:
beans
onions
fruits
certain dairy products
certain carbohydrate-rich products
There are ways to help relieve IBS symptoms. These include:
regular exercise
limiting consumption of caffeinated beverages
minimizing stress
taking probiotics
quitting smoking
Some nutritionists recommend that people with IBS adhere to a low FODMAP diet, an eating plan that focuses on avoiding certain carbohydrates.
'I recommend a multi-component treatment plan including personalized dietary recommendations, behavioral techniques, including self-relaxation techniques, mindfulness-based stress reduction, and cognitive behavioral therapy,' said Mayer.
'In more refractory cases, centrally acting medications like low dose tricyclic antidepressants. In patients with severe psychiatric comorbidity (anxiety or depression, less than 10% of all patients), I prescribed SSRIs,' he added.
Wiznitzer shared some simple advice for people with IBS. 'Manage the anxiety and depression, and the IBS should improve,' he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced that enrollment of the first participants has been completed in a Phase I clinical trial evaluating SCB-1022 (RSV+hMPV) and SCB-1033 (RSV+hMPV+PIV3) respiratory combination vaccine candidates based on prefusion-stabilized F (PreF)-Trimer subunit vaccine antigens utilizing Clover's Trimer-Tag vaccine technology platform. "We are pleased to announce the Phase I clinical trial initiation of our potential first-in-class combination vaccine candidates SCB-1022 (RSV+hMPV) and SCB-1033 (RSV+hMPV+PIV3), further demonstrating the differentiated value of our validated Trimer-Tag platform," said Joshua Liang, Chief Executive Officer & Board Director of Clover. "While currently approved protein-based RSV vaccines are safe & effective, critical gaps persist globally, including the inability to prevent significant respiratory disease burden caused by other viruses related to RSV such as human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3). Thus, we look forward to the clinical trial results for our respiratory combination vaccine candidates in order to maximize our impact on public health globally." In October 2024, Clover announced Phase I results in 70 older adults (60-85 years) for Clover's non-adjuvanted RSV PreF vaccine candidate (SCB-1019) compared head-to-head to GSK's AS01E-adjuvanted RSV vaccine (AREXVY), and results indicated a potential best-in-class combined immunogenicity & tolerability profile of SCB-1019. These results supported the further development and evaluation of SCB-1019 in combination with the PreF-Trimer antigens for hMPV and PIV3, which are also utilizing the Trimer-Tag platform. The ongoing Phase I trial for Clover's combination vaccine candidates is enrolling up to 192 older adults (60-85 years), and the participants will be randomized to receive either SCB-1022 (RSV+hMPV), SCB-1033 (RSV+hMPV+PIV3) or SCB-1019 (RSV) comparator. The study will assess safety, reactogenicity and immunogenicity. About Clover Clover Biopharmaceuticals is a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. With integrated research and development, manufacturing and commercial capabilities as well as strong partnerships with organizations globally, Clover has a diverse pipeline of candidates that have the potential to meaningfully reduce the burden of vaccine-preventable diseases—and to make more diseases preventable. Clover Forward-looking Statements This press release contains certain forward-looking statements and information relating to us and our subsidiaries that are based on the beliefs of our management as well as assumptions made by and information currently available to our management. When used, the words "aim," "anticipate," "believe," "could," "estimate," "expect," "going forward," "intend," "may," "might," "ought to," "plan," "potential," "predict," "project," "seek," "should," "will," "would" and the negative of these words and other similar expressions, as they relate to us or our management, are intended to identify forward-looking statements. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. We give no assurance that these expectations and assumptions will prove to have been correct. Because forward-looking statements relate to the future, they are participant to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. We caution you therefore against placing undue reliance on any of these forward-looking statements. Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time. View original content: SOURCE Clover Biopharma Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
When an Air India flight crashed into a medical campus, surviving doctors rushed to save lives
AHMEDABAD, India — Navin Chaudhary had just begun eating his meal when a loud bang startled him. He turned back to see a massive fire taking over the dining area where he and other trainee doctors had assembled for lunch. The blaze approaching him, he rushed toward a window and jumped. From the ground, looking upward, the sight of the Air India plane's tail cone hanging from the burning building propelled Chaudhary and fellow medical students into action. 'There was fire and many were injured,' said Chaudhary. He said he felt lucky to survive but knew he had a task at hand. He rushed to the hospital's intensive care unit, where the injured, most of whom had burns, were wheeled in on stretchers. 'I felt that as a doctor I could save someone's life,' he said. 'I was safe. So I thought, whatever I can do, I should.' At least 270 died when the Air India flight crashed into the campus of a medical college in Ahmedabad shortly after takeoff on Thursday. Only one passenger among the 242 aboard survived. At least 29 others on the ground, including five medical students inside the hostel, were also killed. Many believe that the death toll would have been higher if it had not been for the intervention of the trainee doctors and students who emerged from the smouldering hostel and rushed to save their colleagues. Akshay Zala, a senior medical student, said the crash felt 'like an earthquake.' 'I could hardly see anything as thick plumes of smoke and dust engulfed everything. I was barely able to breathe,' he said. Zala rushed to safety, running through dust and smoke. He cleaned and bandaged a wound on his left leg then joined others at the medical college's trauma center to treat the injured. On Monday, the crash site teemed with excavators and workers clearing the debris. Officials inspected the building in search of clues that could enable the investigators to figure out what led to the tragedy. Barely a kilometer (less than a mile) away, trainee doctors who survived one of India's worst aviation disasters were still working to identify the victims through DNA testing. Indian authorities have so far handed over the remains of 47 victims The bodies of 92 others have also been identified through DNA matching and will be transferred to relatives soon. College dean Minakshi Parikh said that many of the doctors who pulled their colleagues out of the debris, later that day went back to their duties to save as many lives as they could. 'They did that and that spirit has continued till this moment,' Parikh said. Images of the hostel's dining area shortly after the crash showed parts of the aircraft and pieces of luggage strewn on the floor. Dining plates still containing food lay on the few dusty tables that were left intact by the impact. 'So that is human nature, isn't it? When our own people are injured, our first response is to help them,' Parikh said. 'So the doctors who managed to escape ... the first thing that they did was they went back in and dug out their colleagues who were trapped inside.' 'They might not even have survived because the rescue teams take time coming,' she added.


Health Line
an hour ago
- Health Line
Lung Biopsy for Lung Cancer
Key takeaways A lung biopsy may be used to diagnose lung cancer. There are many kinds of lung biopsies, but common ones include needle, transbronchial, and open. In some cases, prior tests like chest X-rays or CT scans indicate lung cancer may be present, and a lung biopsy may confirm a diagnosis. Scans like a CT scan, MRI scan, or chest X-ray scan may show signs of cancer. If your doctor suspects cancer, a lung biopsy is often used to confirm the diagnosis. A biopsy is a relatively quick procedure that can cause mild discomfort. There are a few different types, but a needle biopsy is one of the most common. Read on to learn more about lung biopsies, how long they take, and what happens when the test is over. How long does a lung cancer biopsy take? There are different types of lung biopsies, and each may take varying amounts of time. Needle lung biopsy A needle biopsy, also called a percutaneous biopsy, means that a doctor will place a needle through the skin and into the lung. Then, they'll draw out a small tissue sample. This procedure takes place under local anesthesia and uses either an ultrasound or CT scanner as a guide. Cancer Research UK reports that a needle lung biopsy usually takes 30 to 45 minutes. Transbronchial biopsy A transbronchial biopsy uses a flexible tube called a bronchoscope to take a sample of tissue from the lungs. The tube is inserted through the nose or mouth and down into the lungs. This procedure involves sedation and usually takes about an hour. Open lung biopsy An open lung biopsy involves making an incision in the side of the body toward the back of the lung. A sample of tissue from the lungs is taken, and the incision is closed with stitches. During this procedure, a chest drain is also inserted to help in the expansion of the lungs during the procedure to allow fluid to drain out. You'll be under anesthesia, and you may need to wait a bit before you can go home. How long does it take to get lung biopsy results? Once a sample is taken from a lung biopsy, it's sent to a laboratory for testing. At the laboratory, a doctor called a pathologist will conduct tests on the sample to determine whether cancer cells are present. During this process, the pathologist may also conduct tests to help classify the type of cancer. Results will then be detailed in a pathology report and sent to your doctor. This report is usually available within a week of the lung biopsy, and your doctor will call you with the results. What does a lung biopsy show? A lung biopsy doesn't technically 'show' anything. However, the tissue sample is tested to determine which type of cells are in your lungs. If cancerous cells are present, the results can confirm a cancer diagnosis. Is a lung biopsy painful? Typically, a lung biopsy causes minor discomfort or no discomfort at all. Sometimes, general anesthetic is used which means you'll be asleep and won't be aware of or feel anything that is happening. If you're not under a general anesthetic, a mild sedative may be administered to help you relax during the procedure. A local anesthetic will be used to numb the area where the needle will be inserted. When this happens, you may feel a slight prick and pressure, but it shouldn't be painful. Some biopsies, like an open biopsy, may require a few days' stay in the hospital. For other procedures with only a light sedative, you may be able to go home once the sedative wears off. You might experience some slight pain at the site of the biopsy once local anesthesia begins to wear off. This will decrease with time, and you'll be given pain relief medication if needed. Sharp pain or pain in the shoulders with breathing can be a sign of a collapsed lung. While uncommon, this can sometimes occur with a needle biopsy. Other symptoms of a collapsed lung may include: rapid heart rate shortness of breath bluish tint to the skin If you have any of these symptoms, you should seek immediate medical attention. Can a lung biopsy cause cancer to spread? Tumor seeding, also called needle seeding, is when a biopsy needle inserted into the body to sample a tumor dislodges cancer cells and allows them to spread along the track of the needle. Studies on this have produced mixed results. While some instances of tumor seeding have been reported, including in lung cancer cases, it is very uncommon. According to the National Cancer Institute, the chance of cancer spreading through a biopsy or surgical procedure is extremely low. Physicians take steps to prevent the spread of cancer cells during biopsies and when removing tumors. For example, if taking tissue from more than one part of the body, different tools are used for each area. Will my doctor help me plan my next steps after results? Once your biopsy results arrive, your doctor will have a discussion with you about the next steps. If cancer is found, more tests may be needed to determine the stage of cancer. Staging refers to the size of a tumor and the extent to which it has spread. Knowing the staging will help determine what treatment options may be best for you. Your doctor will discuss the possible treatment options available to you as well as the pros and cons of each. They'll also discuss the goals of treatment. For instance, sometimes curing lung cancer completely isn't always a realistic goal, so treatment may be focused on controlling cancer and reducing symptoms. It's important to ask questions during this period. It's also a good idea to get a second opinion if you'd like one.